|oral, intranasal, rectal|
|Chemical and physical data|
|Molar mass||217.35 g/mol|
|3D model (JSmol)|
Prolintane (Catovit, Katovit, Promotil, Villescon) is a stimulant and norepinephrine-dopamine reuptake inhibitor developed in the 1950s. It is closely related in chemical structure to other drugs such as pyrovalerone, MDPV, and propylhexedrine and it has a similar mechanism of action. Many cases of prolintane abuse have been reported.
Under the name "Katovit", it was commercialized by the Spanish pharmaceutical company FHER until 2001, mostly as a mental stimulant by students.
- Hollister, L. E.; Gillespie, H. K. (March–April 1970). "A New Stimulant, Prolintane Hydrochloride, Compared with Dextroamphetamine in Fatigued Volunteers". The Journal of Clinical Pharmacology. 10 (2): 103–109. doi:10.1177/009127007001000205. PMID 4392006.
- GB Patent 807835
- Nicholson, A. N.; Stone, B. M.; Jones, M. M. (November 1980). "Wakefullness and reduced rapid eye movement sleep: studies with prolintane and pemoline". British Journal of Clinical Pharmacology. 10 (5): 465–472. doi:10.1111/j.1365-2125.1980.tb01790.x. PMC 1430138
. PMID 7437258.
- Kyle, P. B.; Daley, W. P. (September 2007). "Domestic Abuse of the European Rave Drug Prolintane". Journal of Analytical Toxicology. 31 (7): 415–418. doi:10.1093/jat/31.7.415. PMID 17725890.